Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Hemogenyx Pharmaceuticals Plc.
(OP:
HOPHF
)
0.0031
UNCHANGED
Last Price
Updated: 12:21 PM EDT, Aug 5, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Hemogenyx Pharmaceuticals Plc.
< Previous
1
2
Next >
Hemogenyx Pharmaceuticals PLC Announces Placing to Raise £534,375
November 28, 2023
Via
ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces CBR Expanded to Treatment of Cancer
November 27, 2023
Via
ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces Lentivirus Re-manufacturing Completed
November 15, 2023
Via
ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces Strategic Investment from Prevail Partners, LLC
September 18, 2023
Via
ACCESSWIRE
Hemogenyx Pharmaceuticals PLC - Clinical Hold Lift Plan is accepted by FDA
September 14, 2023
Via
ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces CBR Patent Application Update
September 08, 2023
Via
ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces Result of Annual General Meeting
July 03, 2023
Via
ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces Clinical Hold on IND for HEMO-CAR-T
June 02, 2023
Via
ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces Equity Incentive Pool Increase and Option Grant
April 28, 2023
Via
ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces Full FDA Review for HEMO-CAR-T IND
July 10, 2023
Via
ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces Submission of IND for HEMO-CAR-T
May 09, 2023
Via
ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces Final Results for the Year Ended 31 December 2022
April 28, 2023
Via
ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces HEMO-CAR-T Analytical Release Tests Completed
March 23, 2023
Via
ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces Total Voting Rights
February 28, 2023
Via
ACCESSWIRE
Hemogenyx Pharmaceuticals PLC - HEMO-CAR-T First PQ Run Completed
December 12, 2022
Via
ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces Half-year Report
September 29, 2022
Via
ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces Placing to Raise £4,056,250
January 26, 2023
Via
ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces HEMO-CAR-T 3rd Process Qualification Run Completed
January 23, 2023
Via
ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces Single CBR Can Treat Multiple Viruses
January 09, 2023
Via
ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces HEMO-CAR-T Process Qualification Run Completed
January 04, 2023
Via
ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces Appointment of Director of Quality
August 22, 2022
Via
ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces Approval and Issuance of Antibody Patent
August 15, 2022
Via
ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces Appointment of Medical Director
August 10, 2022
Via
ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces HEMO-CAR-T Process Development Runs Completed
November 18, 2022
Via
ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces Presentation at H.C. Wainwright Global Conference
September 01, 2022
Via
ACCESSWIRE
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.